Ad
Thursday, 22 June 2017
GSK's new CEO aims to divest sports nutrition brand: sources
LONDON (Reuters) - GlaxoSmithKline Plc's new Chief Executive Officer Emma Walmsley is shaking up the British drugmaker's portfolio of smaller products with plans to divest its MaxiNutrition sports nutrition brand, two people familiar with the matter said on Thursday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment